Personal information

Other IDs

Scopus Author ID: 57195513448

Countries

Australia

Activities

Collapse all

Education and qualifications (4)

Royal Australasian College of Physicians: Sydney, NSW, AU

2012 | Fellow
Education
Source: Self-asserted source
James Lynam

Royal College of Physicians: London, London, GB

2006 | Member
Education
Source: Self-asserted source
James Lynam

Imperial College Faculty of Medicine: London, London, GB

2002 | MBBS
Education
Source: Self-asserted source
James Lynam

Imperial College London: London, London, GB

1999 | BSc (hons)
Education
Source: Self-asserted source
James Lynam

Professional activities (5)

Cooperative Trials Group for Neuro-Oncology: Camperdown, New South Wales, AU

2020 to present
Membership
Source: Self-asserted source
James Lynam

Medical Oncology Group of Australia: Sydney, New South Wales, AU

2013 to present
Membership
Source: Self-asserted source
James Lynam

Australian and New Zealand Urogenital and Prostate Cancer Trials Group: Camperdown, New South Wales, AU

2013 to present
Membership
Source: Self-asserted source
James Lynam

European Society for Medical Oncology: Viganello, TI, CH

2012 to present
Membership
Source: Self-asserted source
James Lynam

Royal College of Physicians: London, London, GB

2006 to present
Membership
Source: Self-asserted source
James Lynam

Works (25)

“I’m standing next to him, I’m supporting him”—Supporting a loved one with brain cancer to donate their brain: A qualitative study

Neuro-Oncology Practice
2024-11-15 | Journal article
DOI: 10.1093/nop/npae049
Contributors: Cassandra P Griffin; Melissa A Carlson; Marjorie M Walker; James Lynam; Christine L Paul
Source: check_circle
Crossref

The impact of brain cancer care coordinators on healthcare utilization and outcomes in patients with glioblastoma

Neuro-Oncology Practice
2024-09-13 | Journal article
DOI: 10.1093/nop/npae030
Contributors: Martin Hong; Lucy Leigh; Connor Ballinger; Penny Reeves; Alisha Gooley; Sandy Nixon; Chris Paul; James Lynam
Source: check_circle
Crossref

Understanding the value of brain donation for research to donors, next-of-kin and clinicians: A systematic review

PLOS ONE
2023-12-20 | Journal article
DOI: 10.1371/journal.pone.0295438
Contributors: Cassandra P. Griffin; Luisa Gregori; Jenna R. Bowen; Marjorie M. Walker; James Lynam; Christine L. Paul
Source: check_circle
Crossref

Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations

JCO Oncology Practice
2023-11 | Journal article
DOI: 10.1200/OP.23.00191
Contributors: Ciara Conduit; Jeremy Lewin; Andrew Weickhardt; James Lynam; Shirley Wong; Peter Grimison; Shomik Sengupta; Ganes Pranavan; Francis Parnis; Patricia Bastick et al.
Source: check_circle
Crossref

The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma

Cancers
2023-04-27 | Journal article
DOI: 10.3390/cancers15092514
Contributors: Mark Marsland; Amiee Dowdell; Sam Faulkner; Craig Gedye; James Lynam; Cassandra P. Griffin; Joanne Marsland; Chen Chen Jiang; Hubert Hondermarck
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ProNGF Expression and Targeting in Glioblastoma Multiforme

International Journal of Molecular Sciences
2023-01-13 | Journal article
DOI: 10.3390/ijms24021616
Contributors: Mark Marsland; Amiee Dowdell; Sam Faulkner; Phillip Jobling; Robert A. Rush; Craig Gedye; James Lynam; Cassandra P. Griffin; Mark Baker; Joanne Marsland et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A qualitative study investigating Australian cancer service outpatients’ experience of distress screening and management: what is the personal relevance, acceptability and improvement opportunities from patient perspectives?

Supportive Care in Cancer
2022 | Journal article
DOI: 10.1007/s00520-021-06671-2
EID:

2-s2.0-85119878106

Part of ISSN: 14337339 09414355
Contributors: McCarter, K.; Carlson, M.A.; Baker, A.L.; Paul, C.L.; Lynam, J.; Johnston, L.N.; Fradgley, E.A.
Source: Self-asserted source
James Lynam via Scopus - Elsevier
grade
Preferred source (of 2)‎

Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).

BMC cancer
2022-12 | Journal article
DOI: 10.1186/s12885-022-10407-8
PMID: 36528772
PMC: PMC9758808
Contributors: Day F; Sridharan S; Lynam J; Gedye C; Johnson C; Fraser A; Thompson SR; Michael M; Leong T; Roy A et al.
Source: Self-asserted source
James Lynam via Europe PubMed Central

First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty.

Heart, lung & circulation
2022-12 | Journal article
DOI: 10.1016/j.hlc.2022.11.003
PMID: 36549840
Contributors: Nolan MT; Creati L; Koczwara B; Kritharides L; Lynam J; Lyon AR; Negishi K; Ngo DTM; Thomas L; Vardy J et al.
Source: Self-asserted source
James Lynam via Europe PubMed Central

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer.

Radiation oncology (London, England)
2022-09 | Journal article
DOI: 10.1186/s13014-022-02127-x
PMID: 36104707
PMC: PMC9472395
Contributors: Sridharan S; Day F; Loh J; Lynam J; Smart J; Holt B; Mandaliya H; Bonaventura A; Kumar M; Martin J
Source: Self-asserted source
James Lynam via Europe PubMed Central

Adult medulloblastoma in an Australian population.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2022-06 | Journal article
DOI: 10.1016/j.jocn.2022.06.008
PMID: 35728397
Contributors: Parakh S; Davies A; Westcott K; Roos D; Abou-Hamden A; Ahern E; Lau PKH; Cheruvu S; Pranavan G; Pullar A et al.
Source: Self-asserted source
James Lynam via Europe PubMed Central

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

The New England journal of medicine
2022-06 | Journal article
DOI: 10.1056/nejmoa2200075
PMID: 35657320
PMC: PMC9701133
Contributors: Tie J; Cohen JD; Lahouel K; Lo SN; Wang Y; Kosmider S; Wong R; Shapiro J; Lee M; Harris S et al.
Source: Self-asserted source
James Lynam via Europe PubMed Central

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

2022-03 | Preprint
DOI: 10.21203/rs.3.rs-1463635/v1
PPR: PPR471395
Contributors: Sridha S; Day F; Loh J; Lynam J; Smart J; Holt B; Mandaliya H; Bonaventura A; Kumar M; Martin J
Source: Self-asserted source
James Lynam via Europe PubMed Central

Business as unusual: medical oncology services adapt and deliver during COVID-19

Internal Medicine Journal
2021 | Journal article
DOI: 10.1111/imj.15217
EID:

2-s2.0-85106950177

Part of ISSN: 14455994 14440903
Contributors: Travers, A.; Adler, K.; Blanchard, G.; Bonaventura, T.; Charlton, J.; Day, F.; Healey, L.; Kim, S.; Lombard, J.; Mallesara, G. et al.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Castration failure in prostate carcinoma due to a functioning adrenocortical carcinoma

Endocrinology, Diabetes and Metabolism Case Reports
2021 | Journal article
DOI: 10.1530/EDM-21-0036
EID:

2-s2.0-85121041468

Part of ISSN: 20520573
Contributors: Navani, V.; Lynam, J.F.; Smith, S.; O’neill, C.J.; Rowe, C.W.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme

Biomarker Insights
2021 | Journal article
DOI: 10.1177/11772719211013359
EID:

2-s2.0-85105394105

Part of ISSN: 11772719
Contributors: Griffin, C.; Vilain, R.; King, S.; Nixon, S.; Gooley, A.; Bray, S.; Lynam, J.; Walker, M.M.; Scott, R.J.; Paul, C.
Source: Self-asserted source
James Lynam via Scopus - Elsevier
grade
Preferred source (of 2)‎

Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole.

Neuro-oncology advances
2021-11 | Journal article
DOI: 10.1093/noajnl/vdab168
PMID: 35047819
PMC: PMC8760897
Contributors: Griffin CP; Paul CL; Alexander KL; Walker MM; Hondermarck H; Lynam J
Source: Self-asserted source
James Lynam via Europe PubMed Central
grade
Preferred source (of 2)‎

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

The Lancet Oncology
2020 | Journal article
DOI: 10.1016/S1470-2045(20)30541-6
EID:

2-s2.0-85091519786

Part of ISSN: 14745488 14702045
Contributors: Powles, T.; van der Heijden, M.S.; Castellano, D.; Galsky, M.D.; Loriot, Y.; Petrylak, D.P.; Ogawa, O.; Park, S.H.; Lee, J.-L.; De Giorgi, U. et al.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab

Journal of Clinical Medicine
2020-08 | Journal article | Author
DOI: 10.3390/jcm9082664
Contributors: Doan T. M. Ngo; Trent Williams; Sophie Horder; Leonard Kritharides; Janette Vardy; Hiren Mandaliya; Ina I. C. Nordman; James Lynam; Tony Bonaventura; Aaron L Sverdlov
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Results of a survey of cancer patients’ willingness to travel to participate in a clinical trial

Internal Medicine Journal
2019 | Journal article
DOI: 10.1111/imj.14456
EID:

2-s2.0-85073099017
Contributors: Zdenkowski, N.; Lynam, J.; Sproule, V.; Wall, L.; Searston, J.; Brown, S.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol

BMJ Open
2019 | Journal article
DOI: 10.1136/bmjopen-2019-030731
EID:

2-s2.0-85071258855
Contributors: Martin, J.; Keall, P.; Siva, S.; Greer, P.; Christie, D.; Moore, K.; Dowling, J.; Pryor, D.; Chong, P.; McLeod, N. et al.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients

Internal Medicine Journal
2018 | Journal article
DOI: 10.1111/imj.14000
EID:

2-s2.0-85054291737
Contributors: Arulananda, S.; Lynam, J.; Sem Liew, M.; Wada, M.; Cher, L.; Gan, H.K.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

The Lancet
2018 | Journal article
DOI: 10.1016/S0140-6736(18)31257-1
EID:

2-s2.0-85048592368
Contributors: Shitara, K.; Özgüroğlu, M.; Bang, Y.-J.; Di Bartolomeo, M.; Mandalà, M.; Ryu, M.-H.; Fornaro, L.; Olesiński, T.; Caglevic, C.; Chung, H.C. et al.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Utility of selection methods for specialist medical training: A BEME (best evidence medical education) systematic review: BEME guide no. 45

Medical Teacher
2018 | Journal article
DOI: 10.1080/0142159X.2017.1367375
EID:

2-s2.0-85028547895
Contributors: Roberts, C.; Khanna, P.; Rigby, L.; Bartle, E.; Llewellyn, A.; Gustavs, J.; Newton, L.; Newcombe, J.P.; Davies, M.; Thistlethwaite, J. et al.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Prostate cancer

Cancer Forum
2013 | Journal article
EID:

2-s2.0-84879367250
Contributors: Davis, I.D.; Lynam, J.; Sluka, P.
Source: Self-asserted source
James Lynam via Scopus - Elsevier

Peer review (3 reviews for 3 publications/grants)

Review activity for BMJ open. (1)
Review activity for JNCI cancer spectrum. (1)
Review activity for Neuro-oncology practice. (1)
How many people are using ORCID?